Back to Search
Start Over
The development of Jack Jumper ant venom immunotherapy: our 25 years' experience.
- Source :
-
Internal Medicine Journal . Sep2023, Vol. 53 Issue 9, p1716-1721. 6p. - Publication Year :
- 2023
-
Abstract
- Jack Jumper ant venom allergy is a uniquely Australian medical issue. The stinging ant is a leading cause of insect venom allergy in south‐eastern Australia. An effective venom immunotherapy‐based treatment was successfully developed by the Tasmanian Jack Jumper Allergy Research group. This paper provides a synopsis of our 25 years' research journey in developing this evidence‐based treatment modality. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14440903
- Volume :
- 53
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Internal Medicine Journal
- Publication Type :
- Academic Journal
- Accession number :
- 172302062
- Full Text :
- https://doi.org/10.1111/imj.16217